Omega Healthcare Investors (OHI) - FREE Research Report Booth Daniel J who is Chief Operating Officer at Omega Healthcare Investors sold 20,000 shares at $33.50 on March 28, 2014. Following this transaction, the Chief Operating Officer owned 172,197 shares meaning that the stake was reduced by 10.41% with the 20,000-share transaction. The shares most recently traded at $33.31, down $0.19, or 0.58% since the insider transaction. Historical insider transactions for Omega Healthcare Investors go as follows:
4-Week # shares bought: 32,424
12-Week # shares bought: 32,424
24-Week # shares bought: 78,494
24-Week # shares sold: 9,975
The average volume for Omega Healthcare Investors has been 1.3 million shares per day over the past 30 days. Omega Healthcare Investors has a market cap of $4.2 billion and is part of the financial sector and real estate industry. Shares are up 11.88% year-to-date as of the close of trading on Friday. Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. The stock currently has a dividend yield of 5.95%. The company has a P/E ratio of 22.6. Currently there is 1 analyst that rates Omega Healthcare Investors a buy, 2 analysts rate it a sell, and 3 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on OHI - FREETheStreet Quant Ratings rates Omega Healthcare Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, expanding profit margins and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Omega Healthcare Investors Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.